Clinical Trial Update: Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat [Phase 1]

View source ↗

Summary

This is a Phase 1b trial update of AMG 655 in combination with bortezomib or vorinostat for lymphomas, including Hodgkin lymphoma and various non-Hodgkin lympho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Hodgkin Lymphoma
• Low-grade Non-hodgkin Lymphoma
• Mantle Cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• AMG 655 (AMG-655)
• Bortezomib (bortezomib)
• Vorinostat (vorinostat)

Snippet

Sponsor: Amgen | Conditions: Hodgkin's Lymphoma, Low Grade Lymphoma | Phase 1 | Status: COMPLETED